Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-duration response to levodopa

J G Nutt1, J H Carter, W R Woodward

  • 1Department of Neurology, School of Medicine, Oregon Health Sciences University, Portland 97201, USA.

Neurology
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Transcriptomic and neurochemical analysis of the stellate ganglia in mice highlights sex differences.

Scientific reports·2019
Same author

Transcriptomic and neurochemical analysis of the stellate ganglia in mice highlights sex differences.

Scientific reports·2018
Same author

Case Studies in Neuroscience: A dissociation of balance and posture demonstrated by camptocormia.

Journal of neurophysiology·2017
Same author

Do cognitive measures and brain circuitry predict outcomes of exercise in Parkinson Disease: a randomized clinical trial.

BMC neurology·2015
Same author

Targeting protein tyrosine phosphatase σ after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias.

Nature communications·2015
Same author

Mobility, mood and site of care impact health related quality of life in Parkinson's disease.

Parkinsonism & related disorders·2013
Same journal

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.

Neurology·2026
Same journal

Association of Changes in Intrinsic Capacity With Cognitive Decline and Dementia: A Prospective Cohort Study.

Neurology·2026
Same journal

Role of the Upper Motor Neuron in the Generation of Fasciculations in Early Disease Stages of Amyotrophic Lateral Sclerosis.

Neurology·2026
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
See all related articles

Parkinson's disease patients experience a 22% decline in tapping rate after levodopa withdrawal, indicating the long-duration response is crucial for therapeutic benefit and distinct from short-duration effects.

Area of Science:

  • Neurology
  • Movement Disorders
  • Pharmacology

Background:

  • Levodopa is a primary treatment for Parkinson's disease, managing motor symptoms.
  • The therapeutic effects of levodopa are understood to have both short- and long-duration components.
  • Understanding the distinct contributions of these response types is vital for optimizing Parkinson's disease management.

Purpose of the Study:

  • To investigate the long-duration response to levodopa in Parkinson's disease patients.
  • To determine if the long-duration response is separable from the short-duration response.
  • To assess the impact of levodopa withdrawal on motor function, specifically tapping rate.

Main Methods:

  • 16 patients with Parkinson's disease underwent 3 to 5 days of levodopa withdrawal.

Related Experiment Videos

  • Tapping rate was measured to assess motor function deterioration during the withdrawal period.
  • A short-duration levodopa infusion was administered after the withdrawal period to evaluate its effect.

    • Main Results:

    • Tapping rates significantly deteriorated by 22% during levodopa withdrawal, with decline starting 24 hours after cessation.
    • Motor function decline was more pronounced in the more affected hand for patients with asymmetric symptoms.
    • A 2-hour levodopa infusion post-withdrawal enhanced short-duration response but did not restore the long-duration response.

    Conclusions:

    • The long-duration response to levodopa is a critical aspect of its therapeutic benefit in Parkinson's disease.
    • This long-duration response is pharmacologically distinct from the short-duration response.
    • Levodopa withdrawal significantly impacts motor function, highlighting the sustained effect of the medication.